Difference between revisions of "Projects"
OKripfgans (talk | contribs) |
OKripfgans (talk | contribs) |
||
| Line 17: | Line 17: | ||
[[Ultrasound SWS Biomarker Ctte|Ultrasound SWS Biomarker Committee]] | [[Ultrasound SWS Biomarker Ctte|Ultrasound SWS Biomarker Committee]] | ||
| − | [[AIUM/QIBA Ultrasound Volume Blood Flow Biomarker Ctte|Ultrasound Volume Blood Flow Biomarker Committee] | + | [[AIUM/QIBA Ultrasound Volume Blood Flow Biomarker Ctte|Ultrasound Volume Blood Flow Biomarker Committee]] |
Quantitative Volume Blood Flow is the focused of this committee. A group of clinical and basic science researchers are pursuing this effort in conjunction with industry partners. | Quantitative Volume Blood Flow is the focused of this committee. A group of clinical and basic science researchers are pursuing this effort in conjunction with industry partners. | ||
Latest revision as of 04:16, 18 November 2015
DCE-MRI
<one or two line summary of the project/goal>
FDG-PET
<one or two line summary of the project/goal>
Volumetric CT
Volumetric CT-based biomarkers for parenchymal mass (lung nodule) response assessment has been selected to provide a concrete target to start on.
Work is focused on establishing a QIBA framework to organize and pursue the research-oriented groundwork and the standards-oriented profile development/implementation necessary to put such biomarkers into practice in the hands of clinical and pharma users.
Ultrasound
Ultrasound SWS Biomarker Committee
Ultrasound Volume Blood Flow Biomarker Committee
Quantitative Volume Blood Flow is the focused of this committee. A group of clinical and basic science researchers are pursuing this effort in conjunction with industry partners.